Forcyte Biotechnologies

Developer of automated single-cell contractility screening system for drug discovery

placeLos Angeles, California, United States calendar_todayFounded 2017 groups7 employees language forcytebio.com

Registered entities

Innovation

2 patent families — focus: Physics & computing, Human necessities; filing pace slowing. Cited 9 times.

YearFilings
20202
20221

Investor mix

6 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon